Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-up
Hemasphere
.
2025 May 7;9(5):e70128.
doi: 10.1002/hem3.70128.
eCollection 2025 May.
Authors
Francesco d'Amore
1
2
,
Massimo Federico
3
,
Laurence de Leval
4
,
Fredrik Ellin
5
6
,
Olivier Hermine
7
8
,
Won Seog Kim
9
,
François Lemonnier
10
11
,
Joost S P Vermaat
12
,
Gerald Wulf
13
,
Christian Buske
14
,
Martin Dreyling
15
,
Mats Jerkeman
16
;
ESMO and EHA Guidelines Committees
Affiliations
1
Department of Haematology Aarhus University Hospital Aarhus Denmark.
2
Department of Clinical Medicine Aarhus University Hospital Aarhus Denmark.
3
CHIMOMO Department University of Modena and Reggio Emilia Emilia-Romagna Italy.
4
Department of Laboratory Medicine and Pathology Institute of Pathology, Lausanne University Hospital Lausanne University Lausanne Switzerland.
5
Department of Clinical Sciences Lund University Lund Sweden.
6
Department of Internal Medicine Kalmar County Hospital Kalmar Sweden.
7
Department of Hematology Université de Paris, Assistance Publique-Hôpitaux de Paris (AP-HP) Paris France.
8
Imagine Institute, Hôpital Necker, INSERM U1163 Paris France.
9
School of Medicine, Samsung Medical Center Sungkyunkwan University Seoul Korea.
10
Lymphoid Malignancies Unit Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP) Créteil France.
11
Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, INSERM Créteil France.
12
Department of Hematology Leiden University Medical Centre Leiden The Netherlands.
13
Department of Hematology and Medical Oncology University Medical Center Göttingen Göttingen Germany.
14
Institute of Experimental Cancer Research Ulm Medical University Ulm Sweden.
15
Department of Medicine III Ludwig Maximilian University Munich Germany.
16
Department of Oncology Skåne University Hospital Lund Sweden.
PMID:
40342876
PMCID:
PMC12059256
DOI:
10.1002/hem3.70128
No abstract available